116 related articles for article (PubMed ID: 37856162)
1. Elevated Asprosin Levels in Breast Cancer: Insights from a Comparative Study.
Yur M; Özcan S; Yıldırım N; Özdede MR; Özcan M
J Womens Health (Larchmt); 2024 Feb; 33(2):254-261. PubMed ID: 37856162
[No Abstract] [Full Text] [Related]
2. 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
Nour Eldin EEM; El-Readi MZ; Nour Eldein MM; Alfalki AA; Althubiti MA; Mohamed Kamel HF; Eid SY; Al-Amodi HS; Mirza AA
Clin Breast Cancer; 2019 Apr; 19(2):e385-e393. PubMed ID: 30683611
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA 21 and microRNA 10b: early diagnostic biomarkers of breast cancer in Egyptian females.
Ali M; El Gayar D; Hany N; Ezzat AH; Zeyada R
J Egypt Natl Canc Inst; 2022 Apr; 34(1):16. PubMed ID: 35399150
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
5. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
7. The potential value of serum chemerin in patients with breast cancer.
Song Y; Zhu X; Lin Z; Luo L; Wen D
Sci Rep; 2021 Mar; 11(1):6564. PubMed ID: 33753802
[TBL] [Abstract][Full Text] [Related]
8. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
[TBL] [Abstract][Full Text] [Related]
9. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer.
Nour Eldin EEM; Nour Eldein MM; El-Readi MZ; Mirza AA; Fatani SH; Al-Amodi HS; Althubiti MA; Al-Ezzi EM; Eid SY; Kamel HFM
Oncol Res Treat; 2020; 43(10):506-517. PubMed ID: 32721979
[TBL] [Abstract][Full Text] [Related]
11. TCM tongue diagnosis index of early-stage breast cancer.
Lo LC; Cheng TL; Chen YJ; Natsagdorj S; Chiang JY
Complement Ther Med; 2015 Oct; 23(5):705-13. PubMed ID: 26365451
[TBL] [Abstract][Full Text] [Related]
12. Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages.
Akkus G; Koyuturk LC; Yilmaz M; Hancer S; Ozercan IH; Kuloglu T
Tissue Cell; 2022 Aug; 77():101855. PubMed ID: 35749857
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum levels of glycerol-3- phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer.
Karaosmanoglu Yoneten K; Kasap M; Arga KY; Akpinar G; Utkan NZ
Cancer Biomark; 2022; 34(1):67-76. PubMed ID: 34657876
[TBL] [Abstract][Full Text] [Related]
14. BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy.
Abdelrazek MA; Nageb A; Barakat LA; Abouzid A; Elbaz R
Breast Cancer; 2022 May; 29(3):507-515. PubMed ID: 34994942
[TBL] [Abstract][Full Text] [Related]
15. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.
Lubowicka E; Przylipiak A; Zajkowska M; Piskór BM; Malinowski P; Fiedorowicz W; Ławicki S
Biomed Res Int; 2018; 2018():2124390. PubMed ID: 30151375
[TBL] [Abstract][Full Text] [Related]
16. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
Liu X; Chang Q; Wang H; Qian H; Jiang Y
Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
[TBL] [Abstract][Full Text] [Related]
17. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic importance of S100A9 and S100A12 in breast cancer.
Gunaldi M; Okuturlar Y; Gedikbasi A; Akarsu C; Karabulut M; Kural A
Biomed Pharmacother; 2015 Dec; 76():52-6. PubMed ID: 26653550
[TBL] [Abstract][Full Text] [Related]
19. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
